Aquabeam

What is Aquabeam?

The AquaBeam robotic system is a novel, minimally invasive technology indicated for treating Benign Prostatic Hyperplasia (BPH), one of the most frequent pathologies suffered by men.

Benign prostatic hyperplasia is a benign enlargement of the prostate gland that causes an obstruction to the outflow of urine from the bladder. This causes a deterioration in the quality of voiding function in men, resulting in a sluggish stream, difficulty in initiating urination, increased urinary frequency, the need to urinate at night and a sensation of incomplete emptying, which ultimately results in a decrease in quality of life.

The AquaBeam robotic system allows ablation of prostate tissue (BPH) by means of a jet of saline (water + sodium chloride) at very high speed and high pressure (10,000 PSI), without using any thermal energy, unlike transurethral resection (TUR) and lasers.

The surgical procedure is controlled and carried out through an ultrasound-guided robotic system, in which the surgeon, through continuous ultrasound and cystoscopic control, makes a personalized treatment plan and evaluates with maximum precision the volume of tissue to be removed by the robot. This technology simultaneously combines cystoscope images with ultrasound images taken in real time.

These two imaging modalities provide the surgeon with a complete, multidimensional view of the entire prostate, allowing him or her to create a surgical map of which areas of the prostate to remove and which to avoid. Since each prostate is unique in size and shape, the map can be customized and adapted to each patient's unique anatomy.

Once all parameters have been integrated, the robot performs the procedure quickly, predictably and accurately. After the procedure is completed, a catheter is placed in the bladder, which is usually removed the following day, and the patient is usually discharged after 24-48 hours.